Evidence map›Paper›PMID 37810269›Full record

ArticlePreventive medicine reports2023

Cervical cancer screening pathways in France in 2015-2021, a nationwide study based on medico-administrative data.

Christine Le Bihan-Benjamin, Céline Audiger, Inès Khati, Frédéric de Bels, Philippe Jean Bousquet, Stéphanie Barré

Abstract read
In one paragraph

Article in Preventive medicine reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. High-risk human papillomavirus cervical infection prevalence: a nationwide retrospective study comparing opportunistic and organised screening, France, 2020 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christine Le Bihan-BenjaminHealth Survey Data Science and Assessment Division, National Cancer Institute, 52 avenue André Morizet 92100 Boulogne-Billancourt, France.
Céline AudigerPrevention Department, National Cancer Institute, 52 avenue André Morizet 92100 Boulogne-Billancourt, France.
Inès KhatiHealth Survey Data Science and Assessment Division, National Cancer Institute, 52 avenue André Morizet 92100 Boulogne-Billancourt, France.
Frédéric de BelsPrevention Department, National Cancer Institute, 52 avenue André Morizet 92100 Boulogne-Billancourt, France.
Philippe Jean BousquetHealth Survey Data Science and Assessment Division, National Cancer Institute, 52 avenue André Morizet 92100 Boulogne-Billancourt, France.
Stéphanie BarréPrevention Department, National Cancer Institute, 52 avenue André Morizet 92100 Boulogne-Billancourt, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To better document cervical cancer screening (CCS) pathways, the purpose of our study was to examine CCS pathways among women who had undergone a screening test (opportunistic or organised programme), based on real-life data over a 7-year period. This study used data from the French national health care database (SNDS), which covers almost 100 % of the French population of around 66 million inhabitants. Data from 2015 to 2021 were extracted. More than one quarter (27 %) of women who were at least 25 years old in 2015 and up to 65 years old in 2021 were not screened over the 2015-2021 period. Compared to women who had undergone screening at least once, women who were not screened were older (36 % vs. 23 % in the 50-59 years age group in 2015) and lived in the most deprived urban areas (21 % vs 16 % for less and most deprived respectively). 57 % of women underwent screening within recommended intervals, 13 % of women were under-screened, and 30 % were overscreened. Overall, our study identified that, in 2021, women who participated in the French organised screening programme were less likely to be screened within the recommended interval over the 7-year period. These analyses need to be continued over time in order to assess whether the programme helps reintegrate women into the screening process.

Indexed as

Cancer screeningCervical cancerFranceHuman papillomavirusOrganised cervical cancerScreening programmeScreening trajectories

Identifiers

PMID37810269
PMCPMC10550584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.